# Stick or twist? Cost-effectiveness of siponimod compared with continuing existing disease-modifying therapies in the treatment of active secondary progressive multiple sclerosis in the UK

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/stick-or-twist-cost-effectiveness-of-siponimod-compared-with-continuing-existing/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Stephen Montgomery,F Woodhouse,Umakanth Vudumula,Kapil Gudala,Martin Duddy,Michel Kroes |
| Citations | 12 |
| DOI | 10.1080/13696998.2022.2078103 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2078103?needAccess=true |
| OpenAlex ID | https://openalex.org/W4280534807 |
| PMID | 35575251 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Michel Kroes](https://scholariq.org/researchers/michel-kroes/)

## Paper journal

- [Journal of Medical Economics](https://scholariq.org/journals/journal-of-medical-economics/)

## Paper primary topic

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Paper topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Sphingolipid Metabolism and Signaling](https://scholariq.org/topics/sphingolipid-metabolism-and-signaling/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.